Published in Cold Spring Harb Symp Quant Biol on January 01, 1985
The doublesex proteins of Drosophila melanogaster bind directly to a sex-specific yolk protein gene enhancer. EMBO J (1991) 2.02
Functional redundancy in the tissue-specific enhancer of the Drosophila Sgs-4 gene. EMBO J (1988) 1.21
Three protein binding sites form an enhancer that regulates sex- and fat body-specific transcription of Drosophila yolk protein genes. EMBO J (1995) 1.19
Drosophila transcriptional repressor protein that binds specifically to negative control elements in fat body enhancers. Mol Cell Biol (1992) 1.04
A genetic analysis of intersex, a gene regulating sexual differentiation in Drosophila melanogaster females. Genetics (1995) 1.03
Dissecting the regulatory switches of development: lessons from enhancer evolution in Drosophila. Development (2010) 0.98
Regulation of Drosophila yolk protein genes by an ovary-specific GATA factor. Mol Cell Biol (1995) 0.80
Double nexus-Doublesex is the connecting element in sex determination. Brief Funct Genomics (2015) 0.77
A system for mapping DNA sequences in the chromosomes of Drosophila melanogaster. Cell (1974) 27.33
Filter replicas and permanent collections of recombinant DNA plasmids. Nucleic Acids Res (1979) 8.00
Nuclear localization of EGF receptor and its potential new role as a transcription factor. Nat Cell Biol (2001) 7.22
Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185. Cell (1986) 7.06
Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells. Nat Cell Biol (2001) 6.43
Requirement for neuregulin receptor erbB2 in neural and cardiac development. Nature (1995) 5.91
HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation. Nat Cell Biol (2001) 5.82
The neu oncogene encodes an epidermal growth factor receptor-related protein. Nature (1986) 5.77
Adenovirus DNA. I. Molecular weight and conformation. Proc Natl Acad Sci U S A (1967) 5.55
Reduced levels of hsp90 compromise steroid receptor action in vivo. Nature (1990) 5.23
Beta-catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression. Proc Natl Acad Sci U S A (2000) 4.71
Sequence organization and transcription at two heat shock loci in Drosophila. Proc Natl Acad Sci U S A (1978) 4.04
GRIP1, a transcriptional coactivator for the AF-2 transactivation domain of steroid, thyroid, retinoid, and vitamin D receptors. Mol Cell Biol (1997) 3.26
A comparison of the ribosomal DNA's of Xenopus laevis and Xenopus mulleri: the evolution of tandem genes. J Mol Biol (1972) 3.08
The neu gene: an erbB-homologous gene distinct from and unlinked to the gene encoding the EGF receptor. Science (1985) 2.80
Terminal repetition in non-permuted T3 and T7 bacteriophage DNA molecules. J Mol Biol (1967) 2.61
The isolation and characterization of Drosophila yolk protein genes. Cell (1980) 2.52
Regulatable expression of p21-activated kinase-1 promotes anchorage-independent growth and abnormal organization of mitotic spindles in human epithelial breast cancer cells. J Biol Chem (2000) 2.51
Cyclin D1 is required for transformation by activated Neu and is induced through an E2F-dependent signaling pathway. Mol Cell Biol (2000) 2.47
A tissue-specific transcription enhancer from the Drosophila yolk protein 1 gene. Cell (1986) 2.41
HER-2/neu blocks tumor necrosis factor-induced apoptosis via the Akt/NF-kappaB pathway. J Biol Chem (2000) 2.29
Independent control elements that determine yolk protein gene expression in alternative Drosophila tissues. Proc Natl Acad Sci U S A (1985) 2.26
HER-2/neu promotes androgen-independent survival and growth of prostate cancer cells through the Akt pathway. Cancer Res (2000) 2.25
Differential regulation of glucocorticoid receptor transcriptional activation via AF-1-associated proteins. EMBO J (1999) 2.24
Developmental regulation of Drosophila alpha-tubulin genes. Cell (1982) 2.20
Overexpression of ErbB2 in cancer and ErbB2-targeting strategies. Oncogene (2000) 2.19
Sequence and structure conservation in yolk proteins and their genes. J Mol Biol (1983) 2.10
Enhanced c-erbB-2/neu expression in human ovarian cancer cells correlates with more severe malignancy that can be suppressed by E1A. Cancer Res (1993) 2.07
The PTEN/MMAC1/TEP tumor suppressor gene decreases cell growth and induces apoptosis and anoikis in breast cancer cells. Oncogene (1999) 2.07
The clustered and scrambled arrangement of moderately repetitive elements in Drosophila DNA. Cell (1979) 2.06
Sex-specific transcriptional regulation by the male and female doublesex proteins of Drosophila. Genes Dev (1993) 2.03
Purification and some characteristics of 5S DNA from Xenopus laevis. Proc Natl Acad Sci U S A (1971) 2.03
The doublesex proteins of Drosophila melanogaster bind directly to a sex-specific yolk protein gene enhancer. EMBO J (1991) 2.02
Overexpression of ErbB2 blocks Taxol-induced apoptosis by upregulation of p21Cip1, which inhibits p34Cdc2 kinase. Mol Cell (1998) 2.00
Isolation and analysis of recombinant DNA molecules containing yeast DNA. Gene (1978) 1.99
Glucocorticoid receptor-mediated cell cycle arrest is achieved through distinct cell-specific transcriptional regulatory mechanisms. Mol Cell Biol (1997) 1.95
alpha-Tubulin genes of Drosophila. Cell (1981) 1.91
Tissue-specific and constitutive alpha-tubulin genes of Drosophila melanogaster code for structurally distinct proteins. Proc Natl Acad Sci U S A (1986) 1.90
Denaturation map of the ribosomal DNA of Xenopus laevis. J Mol Biol (1971) 1.89
Mitogen-activated and cyclin-dependent protein kinases selectively and differentially modulate transcriptional enhancement by the glucocorticoid receptor. Mol Cell Biol (1997) 1.88
Interaction between the adhesion receptor, CD44, and the oncogene product, p185HER2, promotes human ovarian tumor cell activation. J Biol Chem (1997) 1.86
The initiator tRNA genes of Drosophila melanogaster: evidence for a tRNA pseudogene. Nucleic Acids Res (1981) 1.82
Antidepressants increase human hippocampal neurogenesis by activating the glucocorticoid receptor. Mol Psychiatry (2011) 1.81
Cationic liposome-mediated E1A gene transfer to human breast and ovarian cancer cells and its biologic effects: a phase I clinical trial. J Clin Oncol (2001) 1.73
Nuclear localization of p185neu tyrosine kinase and its association with transcriptional transactivation. Biochem Biophys Res Commun (1994) 1.71
Molecular cloning of the neu gene: absence of gross structural alteration in oncogenic alleles. Proc Natl Acad Sci U S A (1986) 1.69
Antagonism of glucocorticoid receptor transcriptional activation by the c-Jun N-terminal kinase. Proc Natl Acad Sci U S A (1998) 1.66
Different restriction enzyme-generated sticky DNA ends can be joined in vitro. Nucleic Acids Res (1984) 1.66
Combination of EGFR, HER-2/neu, and HER-3 is a stronger predictor for the outcome of oral squamous cell carcinoma than any individual family members. Clin Cancer Res (1999) 1.60
Protein phosphatase types 1 and/or 2A regulate nucleocytoplasmic shuttling of glucocorticoid receptors. Mol Endocrinol (1991) 1.59
Cross-reactivity of C219 anti-p170(mdr-1) antibody with p185(c-erbB2) in breast cancer cells: cautions on evaluating p170(mdr-1) J Natl Cancer Inst (1997) 1.50
Potentiation of human estrogen receptor alpha transcriptional activation through phosphorylation of serines 104 and 106 by the cyclin A-CDK2 complex. J Biol Chem (1999) 1.48
Hyaluronan promotes CD44v3-Vav2 interaction with Grb2-p185(HER2) and induces Rac1 and Ras signaling during ovarian tumor cell migration and growth. J Biol Chem (2001) 1.45
A novel splice variant of HER2 with increased transformation activity. Mol Carcinog (1998) 1.45
The ets protein PEA3 suppresses HER-2/neu overexpression and inhibits tumorigenesis. Nat Med (2000) 1.39
The sequence of the Drosophila melanogaster gene for yolk protein 1. Nucleic Acids Res (1981) 1.35
Labetalol and urinary catecholamines. Br Med J (1978) 1.34
c-erbB-2/neu overexpression enhances metastatic potential of human lung cancer cells by induction of metastasis-associated properties. Cancer Res (1994) 1.33
Insulating DNA directs ubiquitous transcription of the Drosophila melanogaster alpha 1-tubulin gene. Mol Cell Biol (1994) 1.30
Rho GTPases as modulators of the estrogen receptor transcriptional response. J Biol Chem (2000) 1.29
Differential expression of the c-erbB-2 gene in human small cell and non-small cell lung cancer. Cancer Res (1989) 1.24
Akt activation by estrogen in estrogen receptor-negative breast cancer cells. Cancer Res (2001) 1.23
Oncogenic signals of HER-2/neu in regulating the stability of the cyclin-dependent kinase inhibitor p27. J Biol Chem (2000) 1.23
Role for Hsp90-associated cochaperone p23 in estrogen receptor signal transduction. Mol Cell Biol (1999) 1.22
Selective activation of the glucocorticoid receptor by steroid antagonists in human breast cancer and osteosarcoma cells. J Biol Chem (2000) 1.22
Integrating sex- and tissue-specific regulation within a single Drosophila enhancer. Genes Dev (1995) 1.21
Curcumin inhibits tyrosine kinase activity of p185neu and also depletes p185neu. Clin Cancer Res (1999) 1.21
Three protein binding sites form an enhancer that regulates sex- and fat body-specific transcription of Drosophila yolk protein genes. EMBO J (1995) 1.19
One protein, two enzymes. J Biol Chem (1999) 1.19
DNA regions that regulate the ovarian transcriptional specificity of Drosophila yolk protein genes. Genes Dev (1989) 1.19
Sex-specific and non-sex-specific oligomerization domains in both of the doublesex transcription factors from Drosophila melanogaster. Mol Cell Biol (1996) 1.16
Multiple Mycobacterium antigens induce interferon-gamma production from sarcoidosis peripheral blood mononuclear cells. Clin Exp Immunol (2007) 1.16
Transcriptional repression of the neu protooncogene by the adenovirus 5 E1A gene products. Proc Natl Acad Sci U S A (1990) 1.15
Expression of activated rat neu oncogene is sufficient to induce experimental metastasis in 3T3 cells. Oncogene (1991) 1.13
Suppression of tumorigenicity of breast cancer cells by an epithelial cell adhesion molecule (C-CAM1): the adhesion and growth suppression are mediated by different domains. Oncogene (1997) 1.13
Association of micropapillary urothelial carcinoma of the bladder and BK viruria in kidney transplant recipients. Transpl Infect Dis (2013) 1.12
Synergistic transcriptional activation of the tissue inhibitor of metalloproteinases-1 promoter via functional interaction of AP-1 and Ets-1 transcription factors. J Biol Chem (1996) 1.11
Overexpression of c-erbB-2/neu in breast cancer cells confers increased resistance to Taxol via mdr-1-independent mechanisms. Oncogene (1996) 1.11
High tumoral maspin expression is associated with improved survival of patients with oral squamous cell carcinoma. Oncogene (2000) 1.10
Chemosensitization of HER-2/neu-overexpressing human breast cancer cells to paclitaxel (Taxol) by adenovirus type 5 E1A. Oncogene (1997) 1.09
Recombinant PML adenovirus suppresses growth and tumorigenicity of human breast cancer cells by inducing G1 cell cycle arrest and apoptosis. Oncogene (1998) 1.08
Creation of "super" glucocorticoid receptors by point mutations in the steroid binding domain. J Biol Chem (1991) 1.08
Cloning and characterization of the mouse neu promoter. Oncogene (1992) 1.08
Role of erbB2 in breast cancer chemosensitivity. Bioessays (2000) 1.07
Adenovirus-mediated overexpression of the transcription factor E2F-1 induces apoptosis in human breast and ovarian carcinoma cell lines and does not require p53. Cancer Res (1997) 1.07
Transcriptional repression of the neu protooncogene by estrogen stimulated estrogen receptor. Cancer Res (1992) 1.06
Targeting HER2: recent developments and future directions for breast cancer patients. Semin Oncol (2001) 1.06
Strong correlation between c-erbB-2 overexpression and overall survival of patients with oral squamous cell carcinoma. Clin Cancer Res (1997) 1.05
E1A sensitizes cells to tumor necrosis factor-induced apoptosis through inhibition of IkappaB kinases and nuclear factor kappaB activities. J Biol Chem (1999) 1.05
Distinct glucocorticoid receptor transcriptional regulatory surfaces mediate the cytotoxic and cytostatic effects of glucocorticoids. Mol Cell Biol (1999) 1.04
DOC-2/hDab-2 inhibits ILK activity and induces anoikis in breast cancer cells through an Akt-independent pathway. Oncogene (2001) 1.04